BDBM269506 (4-(2-chlorophenethyl)piperazin-1- yl)(imidazo[1,2-a]pyridin-8- yl)methanone::US10058549, 17

SMILES Clc1ccccc1CCN1CCN(CC1)C(=O)c1cccn2ccnc12

InChI Key InChIKey=DPMWZOFTOGCSCJ-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 269506   

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM269506((4-(2-chlorophenethyl)piperazin-1- yl)(imidazo[1,2...)
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:Radioligand binding assays for human 5-HT2A serotonin receptor were conducted using the 5-HT2 agonist [125I]DOI as radioligand. To define nonspecific...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM269506((4-(2-chlorophenethyl)piperazin-1- yl)(imidazo[1,2...)
Affinity DataIC50: 4nMpH: 7.4 T: 2°CAssay Description:Radioligand binding assays for human 5-HT2A serotonin receptor were conducted using the 5-HT2 agonist [125I]DOI as radioligand. To define nonspecific...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM269506((4-(2-chlorophenethyl)piperazin-1- yl)(imidazo[1,2...)
Affinity DataIC50: 4nMAssay Description:Modulator activity at 5-HT2A receptor (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2021
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM269506((4-(2-chlorophenethyl)piperazin-1- yl)(imidazo[1,2...)
Affinity DataIC50: 4nMAssay Description:Modulator activity at 5-HT2A receptor (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2021
Entry Details Article
PubMed